Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure

NCT00527059 Phase 4 UNKNOWN

The purpose of this study is to evaluate the effect of levosimendan infusion, in addition to standard therapy,on renal function in patients with Acute Heart Failure,compared with standard therapy alone.

Details

Lead sponsor	University of Roma La Sapienza
Phase	Phase 4
Status	UNKNOWN
Enrolment	21
Start date	2007-10
Completion	2008-03

Conditions

• Heart Failure
• Renal Insufficiency

Interventions

• Levosimendan in addition to standard therapy
• spironolactone, beta-blockers,ecc

Primary outcomes

• Primary endpoint: GFR measured by inulin Clearance. — 0, 24. 48 and 72 hours after Levosimendan infusion starting

Countries

Italy